Stay updated with breaking news from Pharma Co. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Appointment culminates multi-year succession plan as FSD focuses on commercialization of its UNBUZZD™ alcohol misuse product and Lucid-MS for neurodegenerative disorders
VANCOUVER, BC / ACCESSWIRE / December 14, 2022 / LOVE Pharma Co. ("LOVE" and or "The Company") (CSE:LUV)(FSE:G1Q0), the Company today announced a strategic move to sell its wholly owned subsidiary Microdoz
Please see the previously announced news from Starton Therapeutics Inc.VANCOUVER, BC / ACCESSWIRE / November 2, 2022 / LOVE Pharma Co. ("LOVE" and or "The Company")(CSE:LUV)(FSE:G1Q0), is please to announce
VANCOUVER, BC / ACCESSWIRE / October 19, 2022 / LOVE Pharma Co. ("LOVE" or the "Company") (CSE:LUV) (FSE:G1Q0), is pleased to announce that it has completed its acquisition (the "Acquisition") ofDoc Hygiene
Dr. Albert Garcia Romeu will serve as head researcher for the Love Pharma's MicroDoz sponsored trial to be conducted at the Johns Hopkins Center for Psychedelic and Consciousness ResearchThe MicroDoz Therapy